Skip to content

World Cancer Day – Shine a Light on the World

World Cancer Day – Shine a Light on the World

In 2018, it was estimated that 1,735,350 new cancer cases would be diagnosed in the United States and 609,640 individuals would pass from the disease [Cancer.gov]. We cannot sit by and ignore this life altering disease, which is why World Cancer Day, recognized on Feb. 4, is such an important awareness campaign to the Arfinn Med team.

This year, the World Cancer Day campaign surrounded itself around the hashtag #IAmandIWill, which invited social media users to share who they are and what they plan to do to show support as an advocate. Additionally, numerous cancer patients and survivors shared their own cancer stories.

Among the many that shared their stories throughout various social media platforms, a handful of celebrities, including Shawn Mendes, Will.i.am. and Sabrina Carpenter, partnered with the World Cancer Day organization to share how they plan to be an advocate. Mendez vowed to use his voice for a positive change, while Sabrina shared that she would love and support those battling the disease.

National Theatre, Niagara Falls
https://twitter.com/uicc

Like most years, World Cancer Day allies also invited famous landmarks around the world to illuminate with an orange glow in support of beating cancer. Some of the monuments that participated this year include Fountain of the Four Rivers, Niagara Falls, Victoria Theatre and more!  

At Arfinn Med, we are dedicated to helping medical professionals and their patients combat debilitating diseases like cancer with the use of medical marijuana. By relying on actual physician experiences regarding patient outcomes, doctors can create reports based on the effectiveness, daily dosage and delivery mode of cannabis treatments specific to various patient demographics. Are you ready to join a nationwide network of medical professionals to learn more about medical marijuana and what it can do for your patients? Join Arfinn Med for FREE today!

Stories you may be interested in

Finally, Georgia can grow medical marijuana. Here’s what you need to know.

Four years ago, Governor Nathan Deal signed into law Haleigh’s Hope Act, which made low-THC cannabis oil legal to use by those with certain medical conditions. However, as it was still against the law to buy or grow marijuana in the state, it was virtually impossible to obtain the oil in Georgia. Patients were forced…
Read More

Arfinn Med March Updates

We are very happy to announce the release of several new functions within the Arfinn Med Platform.  Those include: * Text message updates from patients regarding their treatments * Templating for exam notes  * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More

After A Decade Of Testing, Israeli Medical Cannabis Comes To The US

Cannabis is still federally illegal, so while more than 30 US states allow doctors to recommend it, there is very little medical testing of the substance in America. In Israel however, medical cannabis has been legal for more than ten years and studies on the plant’s ability to alleviate the side-effects of cancer and ease…
Read More

Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease

A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More

July Updates

In our quest to save medical marijuana clinics valuable time, Arfinn Med has continued to release new functionality that improves EMR workflows.  This has led to the development of our new telehealth platform, new automated patient intake emails, and generating all state required documentation.  Continuing on our quest, we are proud to release our new…
Read More

Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says

Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020. Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber…
Read More

Leave a Comment

You must be logged in to post a comment.